Prospective Grant of an Exclusive Patent License: Engineered Tumor Infiltrating Lymphocytes for Cancer Therapy

TitleProspective Grant of an Exclusive Patent License: Engineered Tumor Infiltrating Lymphocytes for Cancer Therapy
ToC Doc Engineered Tumor Infiltrating Lymphocytes for Cancer Therapy
Docket Number2022-08795
Type Notice
Subject Prospective Grant of an Exclusive Patent License:
Engineered Tumor Infiltrating Lymphocytes for Cancer Therapy
Publication Date2022-04-26
Last Updated Date 2022-04-25 08:15:08 -0400
Last Public Inspection2022-04-25
Filed At2022-04-25T08:45:00.000-04:00
PDF 2022-08795_PI.pdf (91182 bytes)
Download TXT / HTML / JSON
Number of Pages 3
Filing Typeregular
AgenciesNational Institutes of Health

You can find the raw source document below...

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied. OFR.report is not affiliated with the Office of the Federal Register or the US government in any way.

© OFR.report 2021